Simplex Trading
ERNA icon

Simplex Trading’s Eterna Therapeutics ERNA Stock Holding History

Simplex Trading’s Portfolio ERNA Stock Details ERNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1
Closed -$4K – 10143
2022
Q2 		$4K Sell
1
-1
-50% -$7.18K ﹤0.01% 8949
2022
Q1 		$31K Hold
2
– – ﹤0.01% 7723
2021
Q4 		$61K Buy
2
+1
+100% +$54.4K ﹤0.01% 6965
2021
Q3 		$189K Hold
1
– – ﹤0.01% 5685
2021
Q2 		$194K Buy
+1
New +$144K ﹤0.01% 5721

Other funds holding ERNA

NW
Naviter Wealth Little Rock, Arkansas $801M AUM 22.2% 1-Year Est. Return
CPWM
Cypress Point Wealth Management Dallas, Texas $492M AUM 22.57% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Simplex Trading's ERNA Position: Q3 2022 in Review

Simplex Trading sold out of Eterna Therapeutics (ERNA) in Q3 2022, closing a stake of 1 share — an estimated $3.45K sold.

Simplex Trading first reported a position in ERNA in Q2 2021 and held it in 4 quarters. The position peaked at $480K in Q2 2021. 31 funds tracked by Wall St. Rank hold ERNA as of Q3 2022.

  • Simplex Trading reported no remaining Eterna Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Simplex Trading sold 1 Eterna Therapeutics share in Q3 2022, an estimated $3.45K.
  • Simplex Trading first reported a position in Eterna Therapeutics in Q2 2021 and held it in 4 quarters.
  • Simplex Trading's Eterna Therapeutics position peaked at $480K in Q2 2021.
  • 31 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q3 2022.

Based on Simplex Trading's 13F filing for Q3 2022, filed 4 Nov 2022.